newsfilter
← Latest News
Business Wire·

PhaseBio Pharmaceuticals and SFJ Pharmaceuticals® Announce Approval of IND Application in China for Bentracimab

Enrollment in the REVERSE-IT global Phase 3 trial from clinical sites in China expected to begin later in 2021 PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization o